Approval · Notice of Compliance 827 · 2002
RATIO-VALPROIC: Notice of Compliance 827
Issued May 15, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 827
- Date
- May 15, 2002
- Company
- Ratiopharm Inc.Ulm, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RATIO-VALPROIC | 02140047 | Cancelled Post Market |
| RATIO-VALPROIC | 02140055 | Cancelled Post Market |
| RATIO-VALPROIC | 02140063 | Cancelled Post Market |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 500 MG per CAP
- SODIUM VALPROATE 50 MG per ML